Kidney Disease - Pipeline Review, H1 2014

Summary

'Kidney Disease - Pipeline Review, H1 2014’, provides an overview of the Kidney Disease’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Kidney Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Disease and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Browse Full Report@ http://www.jsbmarketresearch.com/healthcare-medical/r-kidney-disease-pipeline-review-h1-2014-160397

Scope

• The report provides a snapshot of the global therapeutic landscape of Kidney Disease
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Kidney Disease and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Kidney Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Kidney Disease pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products

Reasons to buy

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Kidney Disease
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Kidney Disease pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For More Related Market Research Reports click here:

• Palatin Technologies, Inc. - Product Pipeline Review - 2014 
• Sandoz Inc. - Product Pipeline Review - 2014
• Healthcare and Medical market Research 

 

 

Digital PCR (dPCR) and qPCR Market by Technology, Product (Instruments, Reagents, Software), End User (Research Lab, Academia, Hospitals, Pharmaceutical & Biotechnology Cos, CROs), Application (Research, Diagnostic, Forensic) Global Forecast to 2019

The global digital PCR (dPCR) and qPCR market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the digital PCR (dPCR) and qPCR market, the Asia-Pacific region is expected to grow at the highest CAGR of ~10.7% in the forecast period. The growth of the digital PCR (dPCR) and qPCR market is driven by factors such as growing geriatric population, technological advancements, rising incidence of infectious diseases and genetic disorders, and increased public-private investments, funds, and grants. However, factors such as high cost of dPCR instruments and limitations of qPCR and dPCR techniques are restraining the growth of this market. Attempts for adoption, implementation of MIQE guidelines for publishing qPCR and dPCR-based research is posing a significant challenge for the growth of the digital PCR (dPCR) and qPCR market.

In this report, the global digital PCR (dPCR) and qPCR market has been segmented on the basis of type of technology (real-time PCR and digital PCR), type of product (instruments, reagents and consumables, and softwares and services), type of end-users (research laboratories and academic institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories) applications and type of application (research, clinical, and forensic applications). The real-time PCR (qPCR) technology market accounted for the largest share of the global digital PCR (dPCR) and qPCR market in 2014, followed by the digital PCR (dPCR) market. Factors such as technological advancements in the field of qPCR, rising adoption of qPCR in research and medical diagnosis, benefits offered by robotics in lab automation, and increasing installation base of qPCR instruments are driving the growth of qPCR technology market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of 39.7% of the global digital PCR (dPCR) and qPCR market in 2014, followed by Europe. The digital PCR (dPCR) and qPCR market in the North America is primarily driven by factors such as increase in public and private funding for development of qPCR and dPCR technology, growing number of cancer patients, continuous reduction in average cost of gene sequencing, and presence of major pharmaceutical companies in the U.S. However, financial constraints faced by market players are limiting the growth of the digital PCR (dPCR) and qPCR market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 10.7% in the next five years, owing to factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel dPCR and qPCR technologies, rise of Indian genomics market, and strengthening cancer research in Japan.

Browse Full Report@ http://www.jsbmarketresearch.com/technology/r-digital-pcr-and-qpcr-market-by-technology-product-end-user-application-global-forecast-161602

The global digital PCR (dPCR) and qPCR market is highly competitive with a large number of global as well as local market players. As of 2013, the global digital PCR (dPCR) and qPCR market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), and F. Hoffmann-La Roche, Ltd. (Switzerland), which together accounted for ~70% of the market. New product launches, product enhancements, and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the global digital PCR (dPCR) and qPCR market.

Reasons To Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis — industry analysis (industry trends and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the qPCR and dPCR market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

 The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on qPCR and dPCR products offered by the top 10 players in the global digital PCR (dPCR) and qPCR market. The report analyzes the digital PCR (dPCR) and qPCR market by type of product, technology, end-user, and application across key geographic region

 Product Development/Innovation: Detailed insights on upcoming qPCR and dPCR technologies, research and development activities, and new product launches in the global digital PCR (dPCR) and qPCR market

 Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various qPCR and dPCR products across key geographic region

 Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global digital PCR (dPCR) and qPCR market

 Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global digital PCR (dPCR) and qPCR market

Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

 Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2014 provides data on the Ampio Pharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Directs proprietary databases, Ampio Pharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Ampio Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Directs team.

Scope

Ampio Pharmaceuticals, Inc. - Brief Ampio Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.

Review of current pipeline of Ampio Pharmaceuticals, Inc. human therapeutic division.

Overview of pipeline therapeutics across various therapy areas.

Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

Product profiles for late stage and clinical stage products of Ampio Pharmaceuticals, Inc. with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.

Recent updates of the Ampio Pharmaceuticals, Inc.s pipeline in the last quarter.

Key discontinued and dormant projects.

Latest news and deals relating to the products.

Browse Full Report@ http://www.jsbmarketresearch.com/healthcare-medical/r-ampio-pharmaceuticals-inc-product-pipeline-review-2014-159835 

Reasons to buy

·        

Evaluate Ampio Pharmaceuticals, Inc.s strategic position with total

access to detailed information on its product pipeline. Assess the growth potential of Ampio Pharmaceuticals, Inc. in its therapy areas of focus.
    

Identify new drug targets and therapeutic classes in the Ampio Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

    

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

   

Exploit collaboration and partnership opportunities with Ampio Pharmaceuticals, Inc..

     

Avoid Intellectual Property Rights related issues.

     

Explore the dormant and discontinued projects of Ampio Pharmaceuticals, Inc. and identify potential opportunities in those areas.

 For More Related Market Research Reports click here:

AmpliPhi Biosciences Corporation - Product Pipeline Review - 2014

Antisense Therapeutics Limited - Product Pipeline Review - 2014

Array BioPharma Inc. - Product Pipeline Review - 2014

Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Benitec Biopharma Limited - Product Pipeline Review - 2014

BioDiem Ltd - Product Pipeline Review - 2014

Bioniche Life Sciences, Inc. - Product Pipeline Review - 2014

CSL Limited - Product Pipeline Review - 2014

Biotron Limited - Product Pipeline Review - 2014

Healthcare and Medical Market Research

Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific

Summary

“Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006 - 2020 period for the following countries: China, Japan, South Korea, Australia and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

• Information on market size for the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices.
• Annualized sales data by revenue for the 2006 - 2020 period and company share data by revenue for 2013
• Annualized sales data by volume for the 2006 - 2020 period
• Coverage of key geographies: China, Japan, South Korea, Australia and India

Browse Full Report@ http://www.jsbmarketresearch.com/healthcare-medical/r-market-digest-aesthetic-lasers-and-energy-devices-market-140102

Reasons to buy

• Derive actionable insights from value-volume relationships
• Analyze value-volume relationships and provide direction to marketing and sales strategies
• Develop market-entry and market-expansion strategies
• Identify the key players best positioned to take advantage of opportunities in the Asia-Pacific market

For More Related Market Research Reports click here:

Market Digest: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Market Digest: Glucose Monitoring Devices 2006 to 2020 - Benelux and Scandinavia   (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)

Market Digest: Mammography Systems 2006 to 2020 - Asia-Pacific (China, Japan, South Korea, Australia, India)

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

Healthcare and Medical Market Research

Allergy Therapeutics plc - Product Pipeline Review - 2014

Summary

Allergy Therapeutics plc - Product Pipeline Review - 2014 provides data on the Allergy Therapeutics plcs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Directs proprietary databases, Allergy Therapeutics plcs corporate website, SEC filings, investor presentations and featured press releases, both from Allergy Therapeutics plc and industry-specific third party sources, put together by Global Markets Directs team.

Scope

• Allergy Therapeutics plc - Brief Allergy Therapeutics plc overview including business description, key information and facts, and its locations and subsidiaries.
• Review of current pipeline of Allergy Therapeutics plc human therapeutic division.
• Overview of pipeline therapeutics across various therapy areas.
• Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
• Product profiles for late stage and clinical stage products of Allergy Therapeutics plc with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
• Recent updates of the Allergy Therapeutics plcs pipeline in the last quarter.
• Key discontinued and dormant projects.
• Latest news and deals relating to the products.
• 
  

Browse Full Report@ http://www.jsbmarketresearch.com/healthcare-medical/r-allergy-therapeutics-plc-product-pipeline-review-2014-159833

Reasons to buy

• Evaluate Allergy Therapeutics plcs strategic position with total access to detailed information on its product pipeline.
• Assess the growth potential of Allergy Therapeutics plc in its therapy areas of focus.
• Identify new drug targets and therapeutic classes in the Allergy Therapeutics plcs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
• Exploit collaboration and partnership opportunities with Allergy Therapeutics plc.
• Avoid Intellectual Property Rights related issues.
• Explore the dormant and discontinued projects of Allergy Therapeutics plc and identify potential opportunities in those areas.
• 
  

Special Discount Offer On Global Markets Direct  Market Research Reports at JSB (Discount Valid till 28th February, 2015)

Buy 2 Reports – 10% discount
Buy 3 to 5 Reports – 15% Discount
Buy 5 to 10 Reports – 20% Discount
Buy 10+ Reports – 25% Discount

Click here and avail Discount offer on market research reports: http://www.jsbmarketresearch.com/discount.php

For more inquiries, contact at +91 - 998 729 5242 /contact@jsbmarketresearch.com

For More Related Market Research Reports click here:

Marburg Hemorrhagic Fever - Pipeline Review, H2 2014

Renal Insufficiency - Pipeline Review, H2 2014

Healthcare and Medical Market Research

Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

Although immunotherapy was first recognized over 100 years ago, it has only become an important therapeutic tool in recent decades. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases.

The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing.

Market access presents a significant hurdle for immunotherapeutics, as many are high cost and do not deliver the measurements required for traditional cost-effectiveness assessments.

Oncology has been a primary area of focus for immunotherapeutics, largely due to the potential offered by this market but also due to the critical role the immune system plays in the proliferation of cancer throughout the body. Auto-immune and inflammatory diseases are also attractive targets for immunotherapy, with several different approaches being investigated.

The report, Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome was written to support executives within both the commercial and R&D sides of the biopharmaceutical industry. It provides key insights through the analysis of issues, trends, and the future outlook of immunological therapies to support executive decision making for both biotech and pharmaceuticals companies alike.

Scope

• Immunotherapy Overview
• Immunotherapeutic Development and Launch Strategies
• Trends in the Development of Immunotherapeutics
• The Immunotherapeutics Market
• Key Companies Involved in Immunotherapeutics
• Case Studies
• Future outlook
• 
  

Browse Full Report@ http://www.jsbmarketresearch.com/healthcare-medical/r-Immunotherapy-Development-Strategies-25045

Key Reasons to Purchase

• Access CBRs insights and analysis on the opportunities which exist within this complicated and fast moving market

• Better understand where both the main opportunities and challenges exist to successfully developing an immunotherapeutic product and what it will take to get there
• Gain a more complete picture of the where the trends in development are taking the future of immunotherapeutics
• Utilize CBRs case study analysis to help support key business decisions
• Benefit from CBRs identification and discussion on the lessons learned when developing an immunotherapeutic product and our outlook on the future of the market

Discounts on Market Research Reports till 28 February, 2015

For more inquiries, contact at +91 - 998 729 5242 /contact@jsbmarketresearch.com

For More Related Market Research Reports click here:

R&D Productivity - The State of Research and Development in the BioPharmaceutical Industry              

Companion Diagnostics - Streamlining drug development and advancing personalized medicine    

Healthcare and Medical Market Research

World Cigarettes - Sri Lanka 2014

Summary

Cigarettes in Sri Lanka is a new report by ERC that focuses on the extent to which Sri Lanka Cigarettes market has evolved in line with changing smoking habits, the competitive environment and economic developments, as well as analyzing the implications market realignments have had on top multinational companies.

Key Findings

Total duty paid sales were 4.13 billion pieces in 2013 with per capita consumption at 191 pieces per person.

The situation is not set to improve greatly during 2014 with duty increases again dampening demand. Sales are set to fall by 2.2% to 4.05 billion pieces.

Sales are forecast at 4.99 billion pieces in 2023, 20.7% up on 2013, while capita consumption is set to increase to 214 pieces, a rise of 12% on 2013.

Synopsis

Cigarettes in Sri Lanka report is a qualitative report providing extensive and highly detailed consumption data on the Cigarettes industry in Sri Lanka.

This report is the result of ERCs extensive market research covering Cigarettes across Sri Lanka. The report provides consumption data based upon a unique combination of industry research, fieldwork, market sizing work and our in-house expertise in the Cigarettes industry in order to offer extensive data about the trends and dynamics affecting the Cigarettes industry.

This report is aimed at companies operating in the Cigarettes industry and for new companies considering entry into Cigarettes industry.

This report provides detailed data of the manufacturers operating in the Cigarettes industry in Sri Lanka.

This report also provides market size of the Cigarettes industry in Sri Lanka along with other data relating to the regulations, retail price, smoking population, production and trade and forecast data.

Browse Full Report@ http://www.jsbmarketresearch.com/consumer-goods/r-world-cigarettes-sri-lanka-2014-158634

Reasons To Buy

Cigarettes companies require a detailed understanding of Cigarettes consumption in order to align their sales and marketing efforts with the latest trends in the market. This report clarifies in detail, by region and company, where the growth opportunities are in Cigarettes industry to enable effective marketing plan

As consumers product demands evolve, the dynamics between different countries also change - favoring some countries and leaving others increasingly out of line with demand patterns. As a result, understanding the shifting market dynamics is key to ensuring maximum sales in the future

The differing growth rates in overall regional product sales drive fundamental shifts in the market. This report provides detailed, authoritative data on these changes for marketers


The report provides the latest data on market dynamics in the Cigarettes industry across Sri Lanka, providing marketers with essential data in order to understand their own position in the market and to identify where to compete in the future

For More Related Market Research Reports click here:

• World Cigarettes - Croatia 2014
• World Cigarettes - Lithuania 2014
• Consumer Goods Market Research

INDIAN LED LIGHTING MARKET FORECAST TO 2019

The Light Emitting Diode (LED) market in India has been growing over 50% for the last five years (2009-10 to 2013-14) and expected to sustain this growth rate in the next five year (2014-15 to 2018-19). Although late, the government of India has announced a lot of incentives and measures in order to prioritize LED manufacturing in the country. However, there are lot of LED Lamp assembling companies in India, who design and make LED lamps but they import basic LED chip elements.

In view of the LED market potential in the country IBNA Research, a division of Indian Business News Agency (IBNA), has published a new market research report titled, “Indian LED Lighting Market Forecast to 2019”.

Browse Full Report@   http://www.jsbmarketresearch.com/electronics/r-indian-led-lighting-market-forecast-144637

The report starts with an introduction of Indias demographic and macroeconomic indicators, including focus on Indian Cities for Growth.

Chapter Two of the report discusses the government regulations, policy and different kinds of licences and registrations for LED lighting industry. The chapter provides market entry strategy, explains entrance routes and analyses the most relevant options for the foreign LED companies to enter in the market.

Chapter Three covers the duties and taxes on LED, especially LED lamps, including detail discussion on tax rates imposed by the central government as well as the state governments.

Chapter Four explains the overall LED industry and the production of LED in India. The chapter provides the information needed to understand the dynamics of the LED industry in the country.

Chapter Five discusses the import and exports of LED including detail statistics of country-wise imports and exports. The chapter provides contact information of major importers and exporters of LED in India.

Chapter Six highlights the Indian consumer income grouping, consumer classes, their characteristics, behavior and preferences. The chapter will help the foreign LED companies to understand the mental makeup of the Indian consumers.

Chapter Seven provides prices of LED lamps in the Indian market. The chapter discusses the mechanism of formation of price of LED lamps in the country.

Chapter Eight provides elaborate coverage of Indian LED market. Providing detail statistics, the chapter analyses the market size, market growth and market share. The chapter categorizes Indian LED market into four product categories – Street Lights, Down Lights, Retrofit Lamps and Luminaires – to provide a detailed overview of past and present performance, both in value and volume terms, of each segment. The segment-wise future outlook has been given in the report which will help readers to identify the future growth spots and the market target. The chapter also provides profiles of the 20 foreign and indigenous LED manufacturing companies, to help clients understand the market, its structure and progress in the coming years.

Chapter Nine highlights various distribution networks existing in the Indian market and the market trends, potential future growth areas, and challenges for the sector.

If you are in the LED industry take a look on the Table of Content and the Figures and Tables that are provided with this description and we are sure that you will benefit greatly from the information compiled in "Indian LED Lighting Market Forecast to 2019

For More Related Market Research Reports click here:

• Global Electricity Distribution and Control Equipment Market to 2019 - Market Size, Growth, and Forecasts in 70 Countries
• Global Lighting Product Market to 2019 - Market Size, Growth, and Forecasts in Nearly 70 Countries
• Electronics Market Research